BioHarvest Sciences Inc. (NASDAQ:BHST) Short Interest Update

Key Points

• BioHarvest Sciences Inc. experienced a significant increase in short interest, rising to 28,700 shares as of September 30th, up by 84.0% from 15,600 shares on September 15th.
• The company reported a quarterly loss of ($0.15) EPS, falling short of analysts' expectations of ($0.11), while revenue was $8.52 million against estimates of $8.53 million.
• Research analysts have mixed views on the stock; while three analysts rate it as a Buy, one has issued a Sell rating, with a consensus rating of "Moderate Buy" and an average price target of $13.67.

BioHarvest Sciences Inc. (NASDAQ:BHST - Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totaling 28,700 shares, an increase of 84.0% from the September 15th total of 15,600 shares. Based on an average trading volume of 45,000 shares, the short-interest ratio is presently 0.6 days. Approximately 0.2% of the shares of the company are sold short. Approximately 0.2% of the shares of the company are sold short. Based on an average trading volume of 45,000 shares, the short-interest ratio is presently 0.6 days.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Weiss Ratings reissued a "sell (e+)" rating on shares of BioHarvest Sciences in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of BioHarvest Sciences to a "hold" rating in a research note on Saturday. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $13.67.

BioHarvest Sciences Stock Performance

NASDAQ BHST opened at $11.28 on Tuesday. The firm has a market cap of $185.27 million, a PE ratio of -16.11 and a beta of 0.78. BioHarvest Sciences has a one year low of $4.66 and a one year high of $12.80. The firm's fifty day moving average is $9.50 and its two-hundred day moving average is $7.69.

BioHarvest Sciences (NASDAQ:BHST - Get Free Report) last posted its quarterly earnings data on Monday, August 11th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.04). The business had revenue of $8.52 million during the quarter, compared to analyst estimates of $8.53 million. BioHarvest Sciences had a negative net margin of 39.95% and a negative return on equity of 11,357.84%. BioHarvest Sciences has set its Q3 2025 guidance at EPS. Research analysts predict that BioHarvest Sciences will post -0.8 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BioHarvest Sciences stock. True North Advisors LLC lifted its position in shares of BioHarvest Sciences Inc. (NASDAQ:BHST - Free Report) by 7.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 44,391 shares of the company's stock after acquiring an additional 3,120 shares during the quarter. True North Advisors LLC owned 0.27% of BioHarvest Sciences worth $275,000 at the end of the most recent quarter.

About BioHarvest Sciences

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.